Opioid Free Anesthesia-Analgesia Strategy and Surgical Stress in Elective Open Abdominal Aortic Aneurysm Repair

Effect of a Perioperative Opioid Free Anesthesia-Analgesia (OFA-A) Strategy on Surgical Stress Response in Elective Open Abdominal Aortic Aneurysm Repair: A Prospective Randomized Study

Open Abdominal Aortic Aneurysm (AAA) repair is a high-risk surgical procedure accompanied by intense endocrine and metabolic responses to surgical stress, with subsequent activation of the inflammatory cascade, cytokine and acute-phase protein release, and bone marrow activation. There is a proven correlation of surgical stress, which patients undergoing open AAA repair are subjected to, with patient outcome, morbidity/mortality, intensive care unit stay and overall length of stay. Modern general anesthetic techniques have been revised and rely on perioperative multimodal anesthetic and analgesic strategies for improved overall patient outcome. Based on this context of a multimodal anesthetic technique and having taken into consideration the international "opioid-crisis" epidemic, an Opioid Free Anesthesia-Analgesia (OFA-A) strategy started to emerge. It is based on the administration of a variety of anesthetic/analgesic agents with different mechanisms of action, including immunomodulating and anti-inflammatory effects.

Our basic hypothesis is that the implementation of a perioperative multimodal OFA-A strategy, involving the administration of pregabalin, ketamine, dexmedetomidine, lidocaine, dexamethasone, dexketoprofen, paracetamol and magnesium sulphate, will lead to attenuation of surgical stress response compared to a conventional Opioid-Based Anesthesia-Analgesia (OBA-A) strategy. Furthermore, the anticipated attenuation of the inflammatory response, is pressumed to be associated with equal or improved analgesia, compared to a perioperative OBA-A technique.

Study Overview

• Status: Recruiting
• Conditions: Postoperative Pain; Anesthesia; Opioid Use; Interleukin 6; Elective Surgical Procedures; Abdominal Aortic Aneurysm Without Rupture; Vascular Surgical Procedure; Immunomodulators
• Intervention / Treatment: Drug: Opioid-Based Anesthesia-Analgesia Strategy; Drug: Opioid-free Anesthesia-Analgesia Strategy

Detailed Description

Open abdominal aortic aneurysm (AAA) repair surgery is a high-risk operation, often performed on high-risk patients. Despite advancements made in diagnosis, management, surgical techniques and treatment of these patients, morbidity and mortality remain high. Mortality after open AAA repair remains higher than the average mortality of the matched population for age and sex. Debate is ongoing as to whether open AAA repair or endovascular aneurysm repair (EVAR) is better in terms of overall long-term survival rate.

Regarding open AAA repair, the very nature of the surgery itself, with surgical trauma, aortic cross clamping and its resulting ischemia-reperfusion injury, and cellular interactions of blood with the biomaterial surface of the graft, causes intense and varied metabolic, endocrine and immunological responses. These surgical stress-related responses are evident as marked increases in inflammatory cytokines such as TNF-a, IL-1a, IL-6, IL-8, IL-10, stimulation of the sympathetic system, and stimulation of the hypothalamic-pituitary-adrenal axis, caused by release of CRH and AVP. High levels of IL-6, peaking at 4-48h after clamp removal, have been associated with serious postoperative complications and its levels reflect the intensity of surgical trauma following AAA repair. Other inflammation markers such as CRP and leukocytes have also been shown to increase postoperatively.

While the surgical technique has been extensively studied as to the role it plays on the control of the surgical stress response, patient outcome, morbidity and overall mortality, fewer studies have been conducted to study the effect of the anesthetic management on these factors. While most of them have been focusing on the comparison of general anesthetic vs regional techniques, only few compare different general anesthetic techniques on patient outcome.

Modern general anesthetic techniques have been revised and rely on a multimodal anesthetic and analgesic perioperative regimen for improved patient outcome. A multimodal regimen requires the administration of at least 2 factors with different mechanisms of action. At least one factor causes inhibition of central sensitization and at least another one inhibits the peripheral sensitization of the nervous system, as a response to painful surgical stimuli, mitigating adverse neuroplasticity. One such example, is an Opioid-Free Anesthetic-Analgesic (OFA-A) strategy, which implements a variety of pharmacological agents, including some with demonstrated immunomodulating and anti-inflammatory effects. Apart from sparing any opioid-related adverse effects, an OFA-A multimodal strategy targets optimal analgesia with a multitude of factors in the lowest possible dose, aiming for additive or synergistic effects. An additional advantage of using an OFA-A technique is the prevention of opioid-induced hyperalgesia.

Our hypothesis is that implementation of a multimodal OFA-A strategy, leads to a decreased sympathetic and inflammatory response, compared to conventional opioid-based anesthetic techniques. A decreased inflammatory and stress response as expressed by reduced levels of IL-6, IL-8, IL-10, TNF-a, CRP, cortisol, arginine vasopressin (AVP), white blood cells count and hemodynamic stability is expected to decrease peripheral and central sensitization, contributing to better postoperative analgesia.

• Study Type: Interventional
• Enrollment (Estimated): 40
• Phase: Phase 4

Contacts and Locations

• Study Contact: Name: George Papastratigakis, MD; Phone Number: 00306979056672; Email: papastratigakisg@gmail.com
• Study Contact Backup: Name: Georgios Stefanakis, MD; Phone Number: 00306978779726; Email: G_Stefanakis@yahoo.com

Study Locations

• Greece
  • Crete
    • Heraklion, Crete, Greece, 71110
      • Recruiting
      • University of Crete
      • Contact: George Papastratigakis, MD; Phone Number: 00306979056672; Email: papastratigakisg@gmail.com

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 40 years to 85 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

1. Patient Consent
2. Age between 40 and 85 years old
3. Patients undergoing Elective Open Abdominal Aortic Infrarenal Aneurysm Repair

Exclusion Criteria:

1. Immunocompromised patients
2. Patients with active infection
3. Reoperation on the aorta
4. Inflammatory bowel Disease
5. Malignancy
6. Chronic Inflammatory conditions (e.g. Rheymatoid arthritis, Psoriatic arthritis)
7. Chronic corticosteroid or immunosuppressive drug use

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Basic Science
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Double

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: Opioid-Based Anesthesia Analgesia; Premedication: IM Midazolam 0.05-0.07mg/kg. Anesthesia induction: Midazolam 0.03mg/kg, Propofol 2-3mg/kg, Fentanyl 1-2mcg/kg and Cisatracurium 0.2mg/kg or alternatively Rocuronium 0.6-1.2mg/kg. Anesthesia maintenance: Desflurane set at approximately 1 MAC, Morphine 0.1-0.12mg/kg, Fentanyl 1-2mcg/kg during induction and 50-100mcg prn, Paracetamol 1g +/- Dexketoprofen trometamol 50mg, along with Ondansetron 4mg or Droperidol 0.625mg. Wound infiltration: Ropivacaine 75-150mg. ICU stay sedation: Remifentanil infusion, until removal of the endotracheal tube. Surgical ward: PCA pump with Morphine for the first 3 postoperative days. Additional postoperative analgesia: Paracetamol 1g x3 +/- Dexketoprofen trometamol 50mg x2. Rescue therapy only: Tramadol 50-100mg.	Drug: Opioid-Based Anesthesia-Analgesia Strategy; A perioperative Opioid-Based multimodal Anesthesia-Analgesia strategy will be implemented as described in the Opioid-Based arm of the study.; Other Names: Opioid-Based Anesthesia; OBA-A
Active Comparator: Opioid-Free Anesthesia Analgesia; Premedication: Pregabalin 50-150mg x2, IM Midazolam 0.05-0.07mg/kg. Anesthesia induction: Midazolam 0.03mg/kg, Dexdmedetomidine 0.5-1mcg/kg, Lidocaine 1mg/kg, Propofol 2-3mg/kg, Ketamine 1-1.5mg/kg, Hyoscine 10mg, Cisatracurium 0.2mg/kg or alternatively Rocuronium 0.6-1.2mg/kg, Magnesium sulphate 2.5-5g and Dexamethasone 8-16mg. Anesthesia maintenance: Desflurane set at ~1 MAC, Dexmedetomidine 0.2-1.2mcg/kg/h, Lidocaine 0.5-1mg/kg/h, Ketamine 0.3-0.5mg/kg prn, Paracetamol 1g +/- Dexketoprofen trometamol 50mg, and Ondansetron 4mg or Droperidol 0.625mg. Wound infiltration: Ropivacaine 75-150mg. ICU sedation: Dexmedetomidine + Lidocaine infusions, until removal of the ETT. Surgical ward: PCA pump with Ketamine, Lidocaine, Clonidine, Droperidol and Midazolam for the first 3 postoperative days. Additionally, Pregabalin 50mg per os x1 and 25mg x1, up to x2, Paracetamol 1g x3 +/- Dexketoprofen trometamol 50mg x2. Rescue therapy only: Tramadol 50-100mg.	Drug: Opioid-free Anesthesia-Analgesia Strategy; A perioperative Opioid-Free multimodal Anesthesia-Analgesia strategy will be implemented as described in the Opioid-Free arm of the study.; Other Names: Opioid-Free Anesthesia; OFA-A

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Haemodynamic Stability - DBP change induction	Haemodynamic Stability as quantified by hemodynamic markers, specifically Diastolic Blood Pressure change 1 minute after anesthesia induction, compared to 1 minute prior. Data will be collected from a pulse contour analysis monitor.	1 minute after anesthesia induction, compared to 1 minute prior
Haemodynamic Stability - DBP change incision	Haemodynamic Stability as quantified by hemodynamic markers, specifically Diastolic Blood Pressure change 1 minute after surgical incision, compared to 1 minute prior. Data will be collected from a pulse contour analysis monitor.	1 minute after surgical incision, compared to 1 minute prior
Haemodynamic Stability - MBP change induction	Haemodynamic Stability as quantified by hemodynamic markers, specifically Mean Blood Pressure change 1 minute after anesthesia induction, compared to 1 minute prior. Data will be collected from a pulse contour analysis monitor.	1 minute after anesthesia induction, compared to 1 minute prior
Haemodynamic Stability - MBP change incision	Haemodynamic Stability as quantified by hemodynamic markers, specifically Mean Blood Pressure change 1 minute after surgical incision, compared to 1 minute prior. Data will be collected from a pulse contour analysis monitor.	1 minute after surgical incision, compared to 1 minute prior
Surgical Stress Response - IL-6 - Preoperatively	Inflammatory response and stress response as quantified by IL-6 serum levels. Blood sample collection will take place in both study groups.	1) Preoperatively (as a baseline)
Surgical Stress Response - IL-6 - 15 minutes after aortic cross-clamp	Inflammatory response and stress response as quantified by IL-6 serum levels. Blood sample collection will take place in both study groups.	2) 15 minutes after aortic cross-clamping
Surgical Stress Response - IL-6 - 60 minutes after aortic cross-clamp	Inflammatory response and stress response as quantified by IL-6 serum levels. Blood sample collection will take place in both study groups.	3) 60 minutes after aortic cross-clamp release
Surgical Stress Response - IL-6 - 24 hours after aortic cross-clamp release	Inflammatory response and stress response as quantified by IL-6 serum levels. Blood sample collection will take place in both study groups.	4) 24 hours after aortic cross-clamp release
Surgical Stress Response - IL-8 - Preoperatively	Inflammatory response and stress response as quantified by IL-8 serum levels. Blood sample collection will take place in both study groups.	1) Preoperatively (as a baseline)
Surgical Stress Response - IL-8 - 15 minutes after aortic cross-clamp	Inflammatory response and stress response as quantified by IL-8 serum levels. Blood sample collection will take place in both study groups.	2) 15 minutes after aortic cross-clamping
Surgical Stress Response - IL-8 - 60 minutes after aortic cross-clamp	Inflammatory response and stress response as quantified by IL-8 serum levels. Blood sample collection will take place in both study groups.	3) 60 minutes after aortic cross-clamp release
Surgical Stress Response - IL-8 - 24 hours after aortic cross-clamp release	Inflammatory response and stress response as quantified by IL-8 serum levels. Blood sample collection will take place in both study groups.	4) 24 hours after aortic cross-clamp release
Surgical Stress Response - IL-10 - Preoperatively	Inflammatory response and stress response as quantified by IL-10 serum levels. Blood sample collection will take place in both study groups.	1) Preoperatively (as a baseline)
Surgical Stress Response - IL-10 - 15 minutes after aortic cross-clamp	Inflammatory response and stress response as quantified by IL-10 serum levels. Blood sample collection will take place in both study groups.	2) 15 minutes after aortic cross-clamping
Surgical Stress Response - IL-10 - 60 minutes after aortic cross-clamp	Inflammatory response and stress response as quantified by IL-10 serum levels. Blood sample collection will take place in both study groups.	3) 60 minutes after aortic cross-clamp release
Surgical Stress Response - IL-10 - 24 hours after aortic cross-clamp release	Inflammatory response and stress response as quantified by IL-10 serum levels. Blood sample collection will take place in both study groups.	4) 24 hours after aortic cross-clamp release
Surgical Stress Response - AVP - Preoperatively	Inflammatory response and stress response as quantified by AVP serum levels. Blood sample collection will take place in both study groups.	1) Preoperatively (as a baseline)
Surgical Stress Response - AVP - 15 minutes after aortic cross-clamp	Inflammatory response and stress response as quantified by AVP serum levels. Blood sample collection will take place in both study groups.	2) 15 minutes after aortic cross-clamping
Surgical Stress Response - AVP - 60 minutes after aortic cross-clamp	Inflammatory response and stress response as quantified by AVP serum levels. Blood sample collection will take place in both study groups.	3) 60 minutes after aortic cross-clamp release
Surgical Stress Response - AVP - 24 hours after aortic cross-clamp release	Inflammatory response and stress response as quantified by AVP serum levels. Blood sample collection will take place in both study groups.	4) 24 hours after aortic cross-clamp release
Surgical Stress Response - TNF-a - Preoperatively	Inflammatory response and stress response as quantified by TNF-a serum levels. Blood sample collection will take place in both study groups.	1) Preoperatively (as a baseline)
Surgical Stress Response - TNF-a - 15 minutes after aortic cross-clamp	Inflammatory response and stress response as quantified by TNF-a serum levels. Blood sample collection will take place in both study groups.	2) 15 minutes after aortic cross-clamping
Surgical Stress Response - TNF-a - 60 minutes after aortic cross-clamp	Inflammatory response and stress response as quantified by TNF-a serum levels. Blood sample collection will take place in both study groups.	3) 60 minutes after aortic cross-clamp release
Surgical Stress Response - TNF-a - 24 hours after aortic cross-clamp release	Inflammatory response and stress response as quantified by TNF-a serum levels. Blood sample collection will take place in both study groups.	4) 24 hours after aortic cross-clamp release
Surgical Stress Response - Cortisol - Preoperatively	Inflammatory response and stress response as quantified by cortisol serum levels. Blood sample collection will take place in both study groups.	1) Preoperatively (as a baseline)
Surgical Stress Response - Cortisol - 15 minutes after aortic cross-clamp	Inflammatory response and stress response as quantified by cortisol serum levels. Blood sample collection will take place in both study groups.	2) 15 minutes after aortic cross-clamping
Surgical Stress Response - Cortisol - 60 minutes after aortic cross-clamp	Inflammatory response and stress response as quantified by cortisol serum levels. Blood sample collection will take place in both study groups.	3) 60 minutes after aortic cross-clamp release
Surgical Stress Response - Cortisol - 24 hours after aortic cross-clamp release	Inflammatory response and stress response as quantified by cortisol serum levels. Blood sample collection will take place in both study groups.	4) 24 hours after aortic cross-clamp release
Surgical Stress Response - CRP - Preoperatively	Inflammatory response and stress response as quantified by CRP serum levels. Blood sample collection will take place in both study groups.	1) Preoperatively (as a baseline)
Surgical Stress Response - CRP - 15 minutes after aortic cross-clamp	Inflammatory response and stress response as quantified by CRP serum levels. Blood sample collection will take place in both study groups.	2) 15 minutes after aortic cross-clamping
Surgical Stress Response - CRP - 60 minutes after aortic cross-clamp	Inflammatory response and stress response as quantified by CRP serum levels. Blood sample collection will take place in both study groups.	3) 60 minutes after aortic cross-clamp release
Surgical Stress Response - CRP - 24 hours after aortic cross-clamp release	Inflammatory response and stress response as quantified by CRP serum levels. Blood sample collection will take place in both study groups.	4) 24 hours after aortic cross-clamp release
Surgical Stress Response - WBC - Preoperatively	Inflammatory response and stress response as quantified by WBC count. Blood sample collection will take place in both study groups.	1) Preoperatively (as a baseline)
Surgical Stress Response - WBC - 15 minutes after aortic cross-clamp	Inflammatory response and stress response as quantified by WBC count. Blood sample collection will take place in both study groups.	2) 15 minutes after aortic cross-clamping
Surgical Stress Response - WBC - 60 minutes after aortic cross-clamp	Inflammatory response and stress response as quantified by WBC count. Blood sample collection will take place in both study groups.	3) 60 minutes after aortic cross-clamp release
Surgical Stress Response - WBC - 24 hours after aortic cross-clamp release	Inflammatory response and stress response as quantified by WBC count. Blood sample collection will take place in both study groups.	4) 24 hours after aortic cross-clamp release
Haemodynamic Stability - Mean PR	Haemodynamic Stability as quantified by hemodynamic markers, specifically Pulse Rate - PR. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. Mean PR will be reported for each patient, extracted from the collected data.	Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Haemodynamic Stability - Minimum PR	Haemodynamic Stability as quantified by hemodynamic markers, specifically Pulse Rate - PR. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. Minimum PR values will be reported for each patient, extracted from the collected data.	Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability - Maximum PR	Haemodynamic Stability as quantified by hemodynamic markers, specifically Pulse Rate - PR. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. Maximum PR will be reported for each patient, extracted from the collected data.	Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability - Standard Deviation PR	Haemodynamic Stability as quantified by hemodynamic markers, specifically Pulse Rate - PR. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. The Standard Deviation of the PR values will be reported for each patient, extracted from the collected data.	Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability - PR change induction	Haemodynamic Stability as quantified by hemodynamic markers, specifically Pulse Rate change 1 minute after anesthesia induction, compared to 1 minute prior. Data will be collected from a pulse contour analysis monitor.	1 minute after anesthesia induction, compared to 1 minute prior
Haemodynamic Stability - PR change incision	Haemodynamic Stability as quantified by hemodynamic markers, specifically Pulse Rate change 1 minute after surgical incision, compared to 1 minute prior. Data will be collected from a pulse contour analysis monitor.	1 minute after surgical incision, compared to 1 minute prior
Haemodynamic Stability - PR change clamp	Haemodynamic Stability as quantified by hemodynamic markers, specifically Pulse Rate change 1 minute after aortic clamping, compared to 1 minute prior. Data will be collected from a pulse contour analysis monitor.	1 minute after aortic clamping, compared to 1 minute prior
Haemodynamic Stability - PR change clamp release 1	Haemodynamic Stability as quantified by hemodynamic markers, specifically Pulse Rate change 1 minute after aortic clamp release of the first lower extremity, compared to 1 minute prior. Data will be collected from a pulse contour analysis monitor.	1 minute after aortic clamp release of the first lower extremity, compared to 1 minute prior
Haemodynamic Stability - PR change clamp release 2	Haemodynamic Stability as quantified by hemodynamic markers, specifically Pulse Rate change 1 minute after aortic clamp release of the second lower extremity, compared to 1 minute prior. Data will be collected from a pulse contour analysis monitor.	1 minute after aortic clamp release of the second lower extremity, compared to 1 minute prior
Haemodynamic Stability - Mean SBP	Haemodynamic Stability as quantified by hemodynamic markers, specifically Systolic Blood Pressure - SAP. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. Mean SBP will be reported for each patient, extracted from the collected data.	Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability - Minimum SBP	Haemodynamic Stability as quantified by hemodynamic markers, specifically Systolic Blood Pressure - SAP. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. Minimum SBP will be reported for each patient, extracted from the collected data.	Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability - Maximum SBP	Haemodynamic Stability as quantified by hemodynamic markers, specifically Systolic Blood Pressure - SAP. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. Maximum SBP will be reported for each patient, extracted from the collected data.	Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability - Standard Deviation SBP	Haemodynamic Stability as quantified by hemodynamic markers, specifically Systolic Blood Pressure - SAP. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. The Standard Deviation of SBP values will be reported for each patient, extracted from the collected data.	Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability - SBP change induction	Haemodynamic Stability as quantified by hemodynamic markers, specifically Systolic Blood Pressure change 1 minute after anesthesia induction, compared to 1 minute prior. Data will be collected from a pulse contour analysis monitor.	1 minute after anesthesia induction, compared to 1 minute prior
Haemodynamic Stability - SBP change incision	Haemodynamic Stability as quantified by hemodynamic markers, specifically Systolic Blood Pressure change 1 minute after surgical incision, compared to 1 minute prior. Data will be collected from a pulse contour analysis monitor.	1 minute after surgical incision, compared to 1 minute prior
Haemodynamic Stability - SBP change clamp	Haemodynamic Stability as quantified by hemodynamic markers, specifically Systolic Blood Pressure change 1 minute after aortic clamping, compared to 1 minute prior. Data will be collected from a pulse contour analysis monitor.	1 minute after aortic clamping, compared to 1 minute prior
Haemodynamic Stability - SBP change clamp release 1	Haemodynamic Stability as quantified by hemodynamic markers, specifically Systolic Blood Pressure change 1 minute after aortic clamp release of the first lower extremity, compared to 1 minute prior. Data will be collected from a pulse contour analysis monitor.	1 minute after aortic clamp release of the first lower extremity, compared to 1 minute prior
Haemodynamic Stability - SBP change clamp release 2	Haemodynamic Stability as quantified by hemodynamic markers, specifically Systolic Blood Pressure change 1 minute after aortic clamp release of the second lower extremity, compared to 1 minute prior. Data will be collected from a pulse contour analysis monitor.	1 minute after aortic clamp release of the second lower extremity, compared to 1 minute prior
Haemodynamic Stability - Mean DBP	Haemodynamic Stability as quantified by hemodynamic markers, specifically Diastolic Blood Pressure - DBP. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. Mean DBP will be reported for each patient, extracted from the collected data.	Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability - Minimum DBP	Haemodynamic Stability as quantified by hemodynamic markers, specifically Diastolic Blood Pressure - DBP. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. Minimum DBP will be reported for each patient, extracted from the collected data.	Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability - Maximum DBP	Haemodynamic Stability as quantified by hemodynamic markers, specifically Diastolic Blood Pressure - DBP. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. Maximum DBP will be reported for each patient, extracted from the collected data.	Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability - Standard Deviation DBP	Haemodynamic Stability as quantified by hemodynamic markers, specifically Diastolic Blood Pressure - DBP. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. The Standard Deviation of DBP values will be reported for each patient, extracted from the collected data.	Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability - DBP change clamp	Haemodynamic Stability as quantified by hemodynamic markers, specifically Diastolic Blood Pressure change 1 minute after aortic clamping, compared to 1 minute prior. Data will be collected from a pulse contour analysis monitor.	1 minute after aortic clamping, compared to 1 minute prior
Haemodynamic Stability - DBP change clamp release 1	Haemodynamic Stability as quantified by hemodynamic markers, specifically Diastolic Blood Pressure change 1 minute after aortic clamp release of the first lower extremity, compared to 1 minute prior. Data will be collected from a pulse contour analysis monitor.	1 minute after aortic clamp release of the first lower extremity, compared to 1 minute prior
Haemodynamic Stability - DBP change clamp release 2	Haemodynamic Stability as quantified by hemodynamic markers, specifically Diastolic Blood Pressure change 1 minute after aortic clamp release of the second lower extremity, compared to 1 minute prior. Data will be collected from a pulse contour analysis monitor.	1 minute after aortic clamp release of the second lower extremity, compared to 1 minute prior
Haemodynamic Stability - Mean MBP	Haemodynamic Stability as quantified by hemodynamic markers, specifically Mean Blood Pressure - MBP. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. Mean MBP will be reported for each patient, extracted from the collected data.	Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability - Minimum MBP	Haemodynamic Stability as quantified by hemodynamic markers, specifically Mean Blood Pressure - MBP. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. Minimum MBP will be reported for each patient, extracted from the collected data.	Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability - Maximum MBP	Haemodynamic Stability as quantified by hemodynamic markers, specifically Mean Blood Pressure - MBP. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. Maximum MBP will be reported for each patient, extracted from the collected data.	Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability - Standard Deviation MBP	Haemodynamic Stability as quantified by hemodynamic markers, specifically Mean Blood Pressure - MBP. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. The Standard Deviation of MBP values will be reported for each patient, extracted from the collected data.	Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability - MBP change clamp	Haemodynamic Stability as quantified by hemodynamic markers, specifically Mean Blood Pressure change 1 minute after aortic clamping, compared to 1 minute prior. Data will be collected from a pulse contour analysis monitor.	1 minute after aortic clamping, compared to 1 minute prior
Haemodynamic Stability - MBP change clamp release 1	Haemodynamic Stability as quantified by hemodynamic markers, specifically Mean Blood Pressure change 1 minute after aortic clamp release of the first lower extremity, compared to 1 minute prior. Data will be collected from a pulse contour analysis monitor.	1 minute after aortic clamp release of the first lower extremity, compared to 1 minute prior
Haemodynamic Stability - MBP change clamp release 2	Haemodynamic Stability as quantified by hemodynamic markers, specifically Mean Blood Pressure change 1 minute after aortic clamp release of the second lower extremity, compared to 1 minute prior. Data will be collected from a pulse contour analysis monitor.	1 minute after aortic clamp release of the second lower extremity, compared to 1 minute prior
Haemodynamic Stability - Mean CO	Haemodynamic Stability as quantified by hemodynamic markers, specifically Cardiac Output - CO. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. Mean CO will be reported for each patient, extracted from the collected data.	Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability - Minimum CO	Haemodynamic Stability as quantified by hemodynamic markers, specifically Cardiac Output - CO. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. Minimum CO will be reported for each patient, extracted from the collected data.	Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability - Maximum CO	Haemodynamic Stability as quantified by hemodynamic markers, specifically Cardiac Output - CO. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. Maximum CO will be reported for each patient, extracted from the collected data.	Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability - Standard Deviation CO	Haemodynamic Stability as quantified by hemodynamic markers, specifically Cardiac Output - CO. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. The Standard Deviation of CO values will be reported for each patient, extracted from the collected data.	Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability - Mean CI	Haemodynamic Stability as quantified by hemodynamic markers, specifically Cardiac Index - CI. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. Mean CI will be reported for each patient, extracted from the collected data.	Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability - Minimum CI	Haemodynamic Stability as quantified by hemodynamic markers, specifically Cardiac Index - CI. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. Minimum CI will be reported for each patient, extracted from the collected data.	Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability - Maximum CI	Haemodynamic Stability as quantified by hemodynamic markers, specifically Cardiac Index - CI. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. Maximum CI will be reported for each patient, extracted from the collected data.	Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability - Standard Deviation CI	Haemodynamic Stability as quantified by hemodynamic markers, specifically Cardiac Index - CI. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. The Standard Deviation of CI values will be reported for each patient, extracted from the collected data.	Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability - Mean SV	Haemodynamic Stability as quantified by hemodynamic markers, specifically Stroke Volume - SV. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. Mean SV will be reported for each patient, extracted from the collected data .	Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability - Minimum SV	Haemodynamic Stability as quantified by hemodynamic markers, specifically Stroke Volume - SV. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. Minimum SV will be reported for each patient, extracted from the collected data .	Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability - Maximum SV	Haemodynamic Stability as quantified by hemodynamic markers, specifically Stroke Volume - SV. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. Maximum SV will be reported for each patient, extracted from the collected data .	Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability - Standard Deviation SV	Haemodynamic Stability as quantified by hemodynamic markers, specifically Stroke Volume - SV. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. The Standard Deviation of SV values will be reported for each patient, extracted from the collected data .	Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability - Mean SVV	Haemodynamic Stability as quantified by hemodynamic markers, specifically Stroke Volume Variation - SVV. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. Mean SVV will be reported for each patient, extracted from the collected data .	Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability - Minimum SVV	Haemodynamic Stability as quantified by hemodynamic markers, specifically Stroke Volume Variation - SVV. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. Minimum SVV will be reported for each patient, extracted from the collected data .	Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability - Maximum SVV	Haemodynamic Stability as quantified by hemodynamic markers, specifically Stroke Volume Variation - SVV. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. Maximum SVV will be reported for each patient, extracted from the collected data .	Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability - Standard Deviation SVV	Haemodynamic Stability as quantified by hemodynamic markers, specifically Stroke Volume Variation - SVV. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. The Standard Deviation of SVV values will be reported for each patient, extracted from the collected data .	Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability - Mean SVI	Haemodynamic Stability as quantified by hemodynamic markers, specifically Stroke Volume Index- SVI. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. Mean SVI will be reported for each patient, extracted from the collected data.	Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability - Minimum SVI	Haemodynamic Stability as quantified by hemodynamic markers, specifically Stroke Volume Index- SVI. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. Minimum SVI will be reported for each patient, extracted from the collected data.	Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability - Maximum SVI	Haemodynamic Stability as quantified by hemodynamic markers, specifically Stroke Volume Index- SVI. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. Maximum SVI will be reported for each patient, extracted from the collected data.	Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability - Standard Deviation SVI	Haemodynamic Stability as quantified by hemodynamic markers, specifically Stroke Volume Index- SVI. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. The Standard Deviation of SVI values will be reported for each patient, extracted from the collected data.	Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability - Tachycardia	Intraoperative Tachycardia (defined as PR≥ 100 bpm), with episodes lasting ≥1 minute. Data will be reported in total seconds of intraoperative tachycardia.	From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Haemodynamic Stability - Bradycardia	Intraoperative Bradycardia (defined as PR≤ 40 bpm), with episodes lasting ≥1 minute. Data will be reported in total seconds of intraoperative bradycardia.	From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Haemodynamic Stability - Hypotension	Intraoperative Hypotension (defined as SBP≤90mmHg or ≤80% of preoperative Baseline), with episodes lasting ≥1 minute. All patients will have a 5 minute preoperative SBP baseline, with measurements every 20 seconds. Intraoperative data will be compared to the mean preoperative 5 minute SPB baseline. Data will be reported in total seconds of intraoperative hypotension.	Baseline: 5 minutes prior to anaesthesia induction. Intraoperative Hypotension: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Haemodynamic Stability - Hypertension	Intraoperative Hypertension (defined as SBP ≥120% of preoperative Baseline), with episodes lasting ≥1 minute. All patients will have a 5 minute preoperative SBP baseline, with measurements every 20 seconds. Intraoperative data will be compared to the mean preoperative 5 minute SPB baseline. Data will be reported in total seconds of intraoperative hypertension.	Baseline: 5 minutes prior to anaesthesia induction. Intraoperative Hypotension: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Haemodynamic Stability - Fluid requirements - Crystalloids - Intraoperatively	Haemodynamic Stability as quantified by hemodynamic markers, specifically Crystaloid Fluid Requirements. Data will be reported in ml/kg*h.	From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Haemodynamic Stability - Fluid requirements - Crystalloids - 24 hours postoperatively	Haemodynamic Stability as quantified by hemodynamic markers, specifically Crystaloid Fluid Requirements. Data will be reported in ml/kg*h.	From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively
Haemodynamic Stability - Fluid requirements - Colloids - Intraoperatively	Haemodynamic Stability as quantified by hemodynamic markers, specifically Colloid Fluid Requirements. Data will be reported in ml/kg*h.	From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Haemodynamic Stability - Fluid requirements - Colloids - 24 hours postoperatively	Haemodynamic Stability as quantified by hemodynamic markers, specifically Colloid Fluid Requirements. Data will be reported in ml/kg*h.	From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively
Haemodynamic Stability - Fluid requirements - Concentrated RBCs - Intraoperatively	Haemodynamic Stability as quantified by hemodynamic markers, specifically Concentrated RBC unit Requirements. Data will be reported in ml.	From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Haemodynamic Stability - Fluid requirements - Concentrated RBCs - 24 hours postoperatively	Haemodynamic Stability as quantified by hemodynamic markers, specifically Concentrated RBC unit Requirements. Data will be reported in ml.	From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively
Haemodynamic Stability - Fluid requirements - Plasma - Intraoperatively	Haemodynamic Stability as quantified by hemodynamic markers, specifically Plasma unit Requirements. Data will be reported in ml.	From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Haemodynamic Stability - Fluid requirements - Plasma - 24 hours postoperatively	Haemodynamic Stability as quantified by hemodynamic markers, specifically Plasma unit Requirements. Data will be reported in ml.	From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively
Haemodynamic Stability - Fluid requirements - Platelets - Intraoperatively	Haemodynamic Stability as quantified by hemodynamic markers, specifically Platelet unit Requirements. Data will be reported in ml.	From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Haemodynamic Stability - Fluid requirements - Platelets - 24 hours postoperatively	Haemodynamic Stability as quantified by hemodynamic markers, specifically Platelet unit Requirements. Data will be reported in ml.	From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively
Haemodynamic Stability - Blood Loss - Intraoperatively	Haemodynamic Stability as quantified by hemodynamic markers, specifically Blood Loss. Data will be reported in ml.	From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Haemodynamic Stability - Blood Loss - 24 hours postoperatively	Haemodynamic Stability as quantified by hemodynamic markers, specifically Blood Loss. Data will be reported in ml.	From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively
Haemodynamic Stability - Fluid Balance - Intraoperatively	Haemodynamic Stability as quantified by hemodynamic markers, specifically Fluid Balance. Data will be reported in ml.	From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Haemodynamic Stability - Fluid Balance - 24 hours postoperatively	Haemodynamic Stability as quantified by hemodynamic markers, specifically Fluid Balance. Data will be reported in ml.	From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively
Haemodynamic Stability - Vasoactive Requirements - Adrenaline - Intraoperatively	Haemodynamic Stability as quantified by hemodynamic markers, specifically Adrenaline requirements. Data will be reported in mg.	From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Haemodynamic Stability - Vasoactive Requirements - Adrenaline - 24 hours postoperatively	Haemodynamic Stability as quantified by hemodynamic markers, specifically Adrenaline requirements. Data will be reported in mg.	From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively
Haemodynamic Stability - Vasoactive Requirements - Noradrenaline - Intraoperatively	Haemodynamic Stability as quantified by hemodynamic markers, specifically Noradrenaline requirements. Data will be reported as an averaged intraoperative rate in mcg/kg*min.	From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Haemodynamic Stability - Vasoactive Requirements - Noradrenaline - 24 hours postoperatively	Haemodynamic Stability as quantified by hemodynamic markers, specifically Noradrenaline requirements. Data will be reported as an averaged rate in mcg/kg*min.	From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively
Haemodynamic Stability - Vasoactive Requirements - Ephedrine - Intraoperatively	Haemodynamic Stability as quantified by hemodynamic markers, specifically Ephedrine requirements. Data will be reported in mg.	From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Haemodynamic Stability - Vasoactive Requirements - Ephedrine - 24 hours postoperatively	Haemodynamic Stability as quantified by hemodynamic markers, specifically Ephedrine requirements. Data will be reported in mg.	From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively
Haemodynamic Stability - Vasoactive Requirements - Phenylephrine - Intraoperatively	Haemodynamic Stability as quantified by hemodynamic markers, specifically Phenylephrine requirements. Data will be reported as an averaged intraoperative rate in mcg/kg*min.	From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Haemodynamic Stability - Vasoactive Requirements - Phenylephrine - 24 hours postoperatively	Haemodynamic Stability as quantified by hemodynamic markers, specifically Phenylephrine requirements.Data will be reported as an averaged rate in mcg/kg*min.	From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively
Haemodynamic Stability - Vasoactive Requirements - Dobutamine - Intraoperatively	Haemodynamic Stability as quantified by hemodynamic markers, specifically Dobutamine requirements. Data will be reported as an averaged intraoperative rate in mcg/kg*min.	From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Haemodynamic Stability - Vasoactive Requirements - Dobutamine - 24 hours postoperatively	Haemodynamic Stability as quantified by hemodynamic markers, specifically Dobutamine requirements. Data will be reported as an averaged rate in mcg/kg*min.	From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively
Haemodynamic Stability - Vasoactive Requirements - Dopamine - Intraoperatively	Haemodynamic Stability as quantified by hemodynamic markers, specifically Dopamine requirements. Data will be reported as an averaged intraoperative rate in mcg/kg*min.	From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Haemodynamic Stability - Vasoactive Requirements - Dopamine - 24 hours postoperatively	Haemodynamic Stability as quantified by hemodynamic markers, specifically Dopamine requirements. Data will be reported as an averaged rate in mcg/kg*min.	From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively
Haemodynamic Stability - Vasoactive Requirements - Nitroglycerine - Intraoperatively	Haemodynamic Stability as quantified by hemodynamic markers, specifically Nitroglycerine requirements. Data will be reported as an averaged intraoperative rate in mcg/kg*min.	From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Haemodynamic Stability - Vasoactive Requirements - Nitroglycerine - 24 hours postoperatively	Haemodynamic Stability as quantified by hemodynamic markers, specifically Nitroglycerine requirements. Data will be reported as an averaged rate in mcg/kg*min.	From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Postoperative pain - Numerical Rating Scale (NRS) - Immediately Postoperatively	Evaluation of patients' pain using scales: Numerical Rating Scale (NRS). The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable").	1) Immediately postoperatively (if awakened prior to ICU admission)
Postoperative pain - Numerical Rating Scale (NRS) - First postoperative day	Evaluation of patients' pain using scales: Numerical Rating Scale (NRS). The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable").	2) First postoperative day
Postoperative pain - Numerical Rating Scale (NRS) - Second postoperative day	Evaluation of patients' pain using scales: Numerical Rating Scale (NRS). The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable").	3) Second postoperative day
Postoperative pain - Numerical Rating Scale (NRS) - Third postoperative day	Evaluation of patients' pain using scales: Numerical Rating Scale (NRS). The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable").	4) Third postoperative day
Postoperative pain - Critical Care Pain Observation Tool (CPOT) - Immediately Postoperatively	Evaluation of patients' pain using scales: Critical Care Pain Observation Tool (CPOT). The scale consists of four behavioral domains: facial expression, body movements, muscle tension and compliance with the ventilation for intubated patients or vocalization for extubated patients. Patient's behavior in each domain is scored between 0 and 2. The possible total score ranges from 0 (no pain) to 8 (maximum pain).	1) Immediately postoperatively (if awakened prior to ICU admission)
Postoperative pain - Critical Care Pain Observation Tool (CPOT) - First postoperative day	Evaluation of patients' pain using scales: Critical Care Pain Observation Tool (CPOT). The scale consists of four behavioral domains: facial expression, body movements, muscle tension and compliance with the ventilation for intubated patients or vocalization for extubated patients. Patient's behavior in each domain is scored between 0 and 2. The possible total score ranges from 0 (no pain) to 8 (maximum pain).	2) First postoperative day
Postoperative pain - Critical Care Pain Observation Tool (CPOT) - Second postoperative day	Evaluation of patients' pain using scales: Critical Care Pain Observation Tool (CPOT). The scale consists of four behavioral domains: facial expression, body movements, muscle tension and compliance with the ventilation for intubated patients or vocalization for extubated patients. Patient's behavior in each domain is scored between 0 and 2. The possible total score ranges from 0 (no pain) to 8 (maximum pain).	3) Second postoperative day
Postoperative pain - Critical Care Pain Observation Tool (CPOT) - Third postoperative day	Evaluation of patients' pain using scales: Critical Care Pain Observation Tool (CPOT). The scale consists of four behavioral domains: facial expression, body movements, muscle tension and compliance with the ventilation for intubated patients or vocalization for extubated patients. Patient's behavior in each domain is scored between 0 and 2. The possible total score ranges from 0 (no pain) to 8 (maximum pain).	4) Third postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Comfort - Intolerable - First postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to how comfortable patients feel with their pain, available answers will be: Intolerable; Tolerable with discomfort; Comfortably manageable; Negligible Pain The percentage of patients that report pain that is "Intolerable" will be reported	1) First postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Comfort - Intolerable - Second postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to how comfortable patients feel with their pain, available answers will be: Intolerable; Tolerable with discomfort; Comfortably manageable; Negligible Pain The percentage of patients that report pain that is "Intolerable" will be reported	2) Second postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Comfort - Intolerable - Third postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to how comfortable patients feel with their pain, available answers will be: Intolerable; Tolerable with discomfort; Comfortably manageable; Negligible Pain The percentage of patients that report pain that is "Intolerable" will be reported	3) Third postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Comfort - Tolerable with discomfort - First postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to how comfortable patients feel with their pain, available answers will be: Intolerable; Tolerable with discomfort; Comfortably manageable; Negligible Pain The percentage of patients that report pain that is "Tolerable with discomfort" will be reported	1) First postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Comfort - Tolerable with discomfort - Second postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to how comfortable patients feel with their pain, available answers will be: Intolerable; Tolerable with discomfort; Comfortably manageable; Negligible Pain The percentage of patients that report pain that is "Tolerable with discomfort" will be reported	2) Second postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Comfort - Tolerable with discomfort - Third postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to how comfortable patients feel with their pain, available answers will be: Intolerable; Tolerable with discomfort; Comfortably manageable; Negligible Pain The percentage of patients that report pain that is "Tolerable with discomfort" will be reported	3) Third postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Comfort - Comfortably manageable - First postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to how comfortable patients feel with their pain, available answers will be: Intolerable; Tolerable with discomfort; Comfortably manageable; Negligible Pain The percentage of patients that report pain that is "Comfortably manageable" will be reported	1) First postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Comfort - Comfortably manageable - Second postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to how comfortable patients feel with their pain, available answers will be: Intolerable; Tolerable with discomfort; Comfortably manageable; Negligible Pain The percentage of patients that report pain that is "Comfortably manageable" will be reported	2) Second postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Comfort - Comfortably manageable - Third postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to how comfortable patients feel with their pain, available answers will be: Intolerable; Tolerable with discomfort; Comfortably manageable; Negligible Pain The percentage of patients that report pain that is "Comfortably manageable" will be reported	3) Third postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Comfort - Negligible Pain - First postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to how comfortable patients feel with their pain, available answers will be: Intolerable; Tolerable with discomfort; Comfortably manageable; Negligible Pain The percentage of patients that report pain that is "Negligible Pain" will be reported	1) First postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Comfort - Negligible Pain - Second postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to how comfortable patients feel with their pain, available answers will be: Intolerable; Tolerable with discomfort; Comfortably manageable; Negligible Pain The percentage of patients that report pain that is "Negligible Pain" will be reported	2) Second postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Comfort - Negligible Pain - Third postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to how comfortable patients feel with their pain, available answers will be: Intolerable; Tolerable with discomfort; Comfortably manageable; Negligible Pain The percentage of patients that report pain that is "Negligible Pain" will be reported	3) Third postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Change in Pain - Getting Worse - First postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to changes in pain perception by patients, available answers will be: Getting worse; About the same; Getting better The percentage of patients that report pain that is "Getting worse" will be reported	1) First postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Change in Pain - Getting Worse - Second postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to changes in pain perception by patients, available answers will be: Getting worse; About the same; Getting better The percentage of patients that report pain that is "Getting worse" will be reported	2) Second postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Change in Pain - Getting Worse - Third postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to changes in pain perception by patients, available answers will be: Getting worse; About the same; Getting better The percentage of patients that report pain that is "Getting worse" will be reported	3) Third postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Change in Pain - About the same - First postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to changes in pain perception by patients, available answers will be: Getting worse; About the same; Getting better The percentage of patients that report pain that is "About the same" will be reported	1) First postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Change in Pain - About the same - Second postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to changes in pain perception by patients, available answers will be: Getting worse; About the same; Getting better The percentage of patients that report pain that is "About the same" will be reported	2) Second postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Change in Pain - About the same - Third postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to changes in pain perception by patients, available answers will be: Getting worse; About the same; Getting better The percentage of patients that report pain that is "About the same" will be reported	3) Third postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Change in Pain - Getting better	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to changes in pain perception by patients, available answers will be: Getting worse; About the same; Getting better The percentage of patients that report pain that is "Getting better" will be reported	1) First postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Change in Pain - Getting better - Second postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to changes in pain perception by patients, available answers will be: Getting worse; About the same; Getting better The percentage of patients that report pain that is "Getting better" will be reported	2) Second postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Change in Pain - Getting better - Third postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to changes in pain perception by patients, available answers will be: Getting worse; About the same; Getting better The percentage of patients that report pain that is "Getting better" will be reported	3) Third postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Pain control - Inadequate pain control - First postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to pain control reported by patients, available answers will be: Inadequate pain control; Effective, just about right; Would like to reduce medication The percentage of patients that report "Inadequate pain control" will be reported	1) First postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Pain control - Inadequate pain control - Second postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to pain control reported by patients, available answers will be: Inadequate pain control; Effective, just about right; Would like to reduce medication The percentage of patients that report "Inadequate pain control" will be reported	2) Second postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Pain control - Inadequate pain control - Third postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to pain control reported by patients, available answers will be: Inadequate pain control; Effective, just about right; Would like to reduce medication The percentage of patients that report "Inadequate pain control" will be reported	3) Third postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Pain control - Effective, just about right - First postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to pain control reported by patients, available answers will be: Inadequate pain control; Effective, just about right; Would like to reduce medication The percentage of patients that report pain control that is "Effective, just about right" will be reported	1) First postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Pain control - Effective, just about right - Second postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to pain control reported by patients, available answers will be: Inadequate pain control; Effective, just about right; Would like to reduce medication The percentage of patients that report pain control that is "Effective, just about right" will be reported	2) Second postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Pain control - Effective, just about right - Third postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to pain control reported by patients, available answers will be: Inadequate pain control; Effective, just about right; Would like to reduce medication The percentage of patients that report pain control that is "Effective, just about right" will be reported	3) Third postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Pain control - Would like to reduce medication - First postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to pain control reported by patients, available answers will be: Inadequate pain control; Effective, just about right; Would like to reduce medication The percentage of patients whose pain control is reported as "Would like to reduce medication" will be reported	1) First postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Pain control - Would like to reduce medication - Second postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to pain control reported by patients, available answers will be: Inadequate pain control; Effective, just about right; Would like to reduce medication The percentage of patients whose pain control is reported as "Would like to reduce medication" will be reported	2) Second postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Pain control - Would like to reduce medication - Third postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to pain control reported by patients, available answers will be: Inadequate pain control; Effective, just about right; Would like to reduce medication The percentage of patients whose pain control is reported as "Would like to reduce medication" will be reported	3) Third postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Functioning - Can't do anything because of pain - First postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to functioning - for the usual things patients need to do, available answers will be: Can't do anything because of pain; Pain keeps me from doing most of what I need to do; Can do most things, but pain gets in the way of some; Can do everything I need to do The percentage of patients whose functioning is reported as "Can't do anything because of pain" will be reported	1) First postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Functioning - Can't do anything because of pain - Second postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to functioning - for the usual things patients need to do, available answers will be: Can't do anything because of pain; Pain keeps me from doing most of what I need to do; Can do most things, but pain gets in the way of some; Can do everything I need to do The percentage of patients whose functioning is reported as "Can't do anything because of pain" will be reported	2) Second postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Functioning - Can't do anything because of pain - Third postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to functioning - for the usual things patients need to do, available answers will be: Can't do anything because of pain; Pain keeps me from doing most of what I need to do; Can do most things, but pain gets in the way of some; Can do everything I need to do The percentage of patients whose functioning is reported as "Can't do anything because of pain" will be reported	3) Third postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Functioning - Pain keeps me from doing most of what I need to do - First postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to functioning - for the usual things patients need to do, available answers will be: Can't do anything because of pain; Pain keeps me from doing most of what I need to do; Can do most things, but pain gets in the way of some; Can do everything I need to do The percentage of patients whose functioning is reported as "Pain keeps me from doing most of what I need to do" will be reported	1) First postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Functioning - Pain keeps me from doing most of what I need to do - Second postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to functioning - for the usual things patients need to do, available answers will be: Can't do anything because of pain; Pain keeps me from doing most of what I need to do; Can do most things, but pain gets in the way of some; Can do everything I need to do The percentage of patients whose functioning is reported as "Pain keeps me from doing most of what I need to do" will be reported	2) Second postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Functioning - Pain keeps me from doing most of what I need to do - Third postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to functioning - for the usual things patients need to do, available answers will be: Can't do anything because of pain; Pain keeps me from doing most of what I need to do; Can do most things, but pain gets in the way of some; Can do everything I need to do The percentage of patients whose functioning is reported as "Pain keeps me from doing most of what I need to do" will be reported	3) Third postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Functioning - Can do most things, but pain gets in the way of some - First postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to functioning - for the usual things patients need to do, available answers will be: Can't do anything because of pain; Pain keeps me from doing most of what I need to do; Can do most things, but pain gets in the way of some; Can do everything I need to do The percentage of patients whose functioning is reported as "Can do most things, but pain gets in the way of some" will be reported	1) First postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Functioning - Can do most things, but pain gets in the way of some - Second postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to functioning - for the usual things patients need to do, available answers will be: Can't do anything because of pain; Pain keeps me from doing most of what I need to do; Can do most things, but pain gets in the way of some; Can do everything I need to do The percentage of patients whose functioning is reported as "Can do most things, but pain gets in the way of some" will be reported	2) Second postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Functioning - Can do most things, but pain gets in the way of some - Third postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to functioning - for the usual things patients need to do, available answers will be: Can't do anything because of pain; Pain keeps me from doing most of what I need to do; Can do most things, but pain gets in the way of some; Can do everything I need to do The percentage of patients whose functioning is reported as "Can do most things, but pain gets in the way of some" will be reported	3) Third postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Functioning - Can do everything I need to do - First postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to functioning - for the usual things patients need to do, available answers will be: Can't do anything because of pain; Pain keeps me from doing most of what I need to do; Can do most things, but pain gets in the way of some; Can do everything I need to do The percentage of patients whose functioning is reported as "Can do everything I need to do" will be reported	1) First postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Functioning - Can do everything I need to do - Second postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to functioning - for the usual things patients need to do, available answers will be: Can't do anything because of pain; Pain keeps me from doing most of what I need to do; Can do most things, but pain gets in the way of some; Can do everything I need to do The percentage of patients whose functioning is reported as "Can do everything I need to do" will be reported	2) Second postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Functioning - Can do everything I need to do - Third postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to functioning - for the usual things patients need to do, available answers will be: Can't do anything because of pain; Pain keeps me from doing most of what I need to do; Can do most things, but pain gets in the way of some; Can do everything I need to do The percentage of patients whose functioning is reported as "Can do everything I need to do" will be reported	3) Third postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Sleep - Awake with pain most of the night - First postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to sleep, if the pain is waking patients up, available answers will be: Awake with pain most of the night; Awake with occasional pain; Normal sleep The percentage of patients whose sleep is reported as "Awake with pain most of the night" will be reported	1) First postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Sleep - Awake with pain most of the night - Second postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to sleep, if the pain is waking patients up, available answers will be: Awake with pain most of the night; Awake with occasional pain; Normal sleep The percentage of patients whose sleep is reported as "Awake with pain most of the night" will be reported	2) Second postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Sleep - Awake with pain most of the night - Third postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to sleep, if the pain is waking patients up, available answers will be: Awake with pain most of the night; Awake with occasional pain; Normal sleep The percentage of patients whose sleep is reported as "Awake with pain most of the night" will be reported	3) Third postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Sleep - Awake with occasional pain - First postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to sleep, if the pain is waking patients up, available answers will be: Awake with pain most of the night; Awake with occasional pain; Normal sleep The percentage of patients whose sleep is reported as "Awake with occasional pain" will be reported	1) First postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Sleep - Awake with occasional pain - Second postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to sleep, if the pain is waking patients up, available answers will be: Awake with pain most of the night; Awake with occasional pain; Normal sleep The percentage of patients whose sleep is reported as "Awake with occasional pain" will be reported	2) Second postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Sleep - Awake with occasional pain - Third postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to sleep, if the pain is waking patients up, available answers will be: Awake with pain most of the night; Awake with occasional pain; Normal sleep The percentage of patients whose sleep is reported as "Awake with occasional pain" will be reported	3) Third postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Sleep - Normal sleep - First postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to sleep, if the pain is waking patients up, available answers will be: Awake with pain most of the night; Awake with occasional pain; Normal sleep The percentage of patients whose sleep is reported as "Normal sleep" will be reported	1) First postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Sleep - Normal sleep - Second postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to sleep, if the pain is waking patients up, available answers will be: Awake with pain most of the night; Awake with occasional pain; Normal sleep The percentage of patients whose sleep is reported as "Normal sleep" will be reported	2) Second postoperative day
Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Sleep - Normal sleep - Third postoperative day	Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to sleep, if the pain is waking patients up, available answers will be: Awake with pain most of the night; Awake with occasional pain; Normal sleep The percentage of patients whose sleep is reported as "Normal sleep" will be reported	3) Third postoperative day
Analgesic Requirements - First postoperative day	Evaluation of patients' pain by recording the number of times that rescue analgesia (tramadol) was required.	1) First postoperative day
Analgesic Requirements - Second postoperative day	Evaluation of patients' pain by recording the number of times that rescue analgesia (tramadol) was required.	2) Second postoperative day
Analgesic Requirements - Third postoperative day	Evaluation of patients' pain by recording the number of times that rescue analgesia (tramadol) was required.	3) Third postoperative day
Kidney function - Furosemide requirement - Intraoperatively	Kidney function as quantified by furosemide requirement to maintain urine output. Data will be reported in mg.	From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Kidney function - Furosemide requirement - 24 hours postoperatively	Kidney function as quantified by furosemide requirement to maintain urine output. Data will be reported in mg.	From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively
Kidney function - MDRD GFR - Preoperatively	Kidney function as assessed by preoperative GFR calculated by the MDRD GFR equation.	1) Preoperatively (as a baseline)
Kidney function - MDRD GFR - Immediately postoperatively	Kidney function as assessed by postoperative GFR calculated by the MDRD GFR equation.	2) At the end of surgery 1h after the end of placement of last suture/surgical clip on patient, upon ICU admission.
Kidney function - MDRD GFR - 24h Postoperatively	Kidney function as assessed by postoperative GFR calculated by the MDRD GFR equation.	3) 24h postoperatively
Kidney function - Urine Output - Intraoperatively	Kidney function as quantified by urine output. Data will be reported as an averaged intraoperative rate in ml/kg*h.	From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Kidney function - Urine Output - 24 hours postoperatively	Kidney function as quantified by urine output. Data will be reported as an averaged rate in ml/kg*h.	From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively
Length of stay - ICU	All patients will spend at least 1 day in the ICU for postoperative monitoring. ICU length of stay will be reported in days.	From day of surgery until day of ICU stay.
Length of stay - Hospital Discharge	Hospital length of stay will be reported in days.	From day of surgery until hospital discharge

Collaborators and Investigators

• Sponsor: University of Crete
• Collaborators: University Hospital of Crete
• Investigators: Study Chair: Vasileia Nyktari, MD,PhD, University of Crete, Medical School

Publications and helpful links

General Publications

• Norman PE, Semmens JB, Lawrence-Brown MM. Long-term relative survival following surgery for abdominal aortic aneurysm: a review. Cardiovasc Surg. 2001 Jun;9(3):219-24. doi: 10.1016/s0967-2109(00)00126-5.
• Johal AS, Loftus IM, Boyle JR, Heikkila K, Waton S, Cromwell DA. Long-term survival after endovascular and open repair of unruptured abdominal aortic aneurysm. Br J Surg. 2019 Dec;106(13):1784-1793. doi: 10.1002/bjs.11215.
• Moris DN, Kontos MI, Mantonakis EI, Athanasiou AK, Spartalis ED, Bakoyiannis CN, Chrousos GP, Georgopoulos SE. Concept of the aortic aneurysm repair-related surgical stress: a review of the literature. Int J Clin Exp Med. 2014 Sep 15;7(9):2402-12. eCollection 2014.
• Tsilimigras DI, Sigala F, Karaolanis G, Ntanasis-Stathopoulos I, Spartalis E, Spartalis M, Patelis N, Papalampros A, Long C, Moris D. Cytokines as biomarkers of inflammatory response after open versus endovascular repair of abdominal aortic aneurysms: a systematic review. Acta Pharmacol Sin. 2018 Jul;39(7):1164-1175. doi: 10.1038/aps.2017.212. Epub 2018 May 17.
• Pearson S, Hassen T, Spark JI, Cabot J, Cowled P, Fitridge R. Endovascular repair of abdominal aortic aneurysm reduces intraoperative cortisol and perioperative morbidity. J Vasc Surg. 2005 Jun;41(6):919-25. doi: 10.1016/j.jvs.2005.02.040.
• Wilt TJ, Lederle FA, Macdonald R, Jonk YC, Rector TS, Kane RL. Comparison of endovascular and open surgical repairs for abdominal aortic aneurysm. Evid Rep Technol Assess (Full Rep). 2006 Aug;(144):1-113.
• Moore WS, Kashyap VS, Vescera CL, Quinones-Baldrich WJ. Abdominal aortic aneurysm: a 6-year comparison of endovascular versus transabdominal repair. Ann Surg. 1999 Sep;230(3):298-306; discussion 306-8. doi: 10.1097/00000658-199909000-00003.
• Salartash K, Sternbergh WC 3rd, York JW, Money SR. Comparison of open transabdominal AAA repair with endovascular AAA repair in reduction of postoperative stress response. Ann Vasc Surg. 2001 Jan;15(1):53-9. doi: 10.1007/s100160010014.
• Panaretou V, Siafaka I, Theodorou D, Manouras A, Seretis C, Gourgiotis S, Katsaragakis S, Sigala F, Zografos G, Filis K. Combined general-epidural anesthesia with continuous postoperative epidural analgesia preserves sigmoid colon perfusion in elective infrarenal aortic aneurysm repair. Saudi J Anaesth. 2012 Oct-Dec;6(4):373-9. doi: 10.4103/1658-354X.105870.
• Jessula S, Atkinson L, Casey P, Kwofie K, Stewart S, Lee MS, Smith M, Herman CR. Surgically positioned paravertebral catheters and postoperative analgesia after open abdominal aortic aneurysm repair. J Vasc Surg. 2019 Nov;70(5):1479-1487. doi: 10.1016/j.jvs.2019.02.037. Epub 2019 May 29.
• Panaretou V, Toufektzian L, Siafaka I, Kouroukli I, Sigala F, Vlachopoulos C, Katsaragakis S, Zografos G, Filis K. Postoperative pulmonary function after open abdominal aortic aneurysm repair in patients with chronic obstructive pulmonary disease: epidural versus intravenous analgesia. Ann Vasc Surg. 2012 Feb;26(2):149-55. doi: 10.1016/j.avsg.2011.04.009. Epub 2011 Oct 22.
• Greco KJ, Brovman EY, Nguyen LL, Urman RD. The Impact of Epidural Analgesia on Perioperative Morbidity or Mortality after Open Abdominal Aortic Aneurysm Repair. Ann Vasc Surg. 2020 Jul;66:44-53. doi: 10.1016/j.avsg.2019.10.054. Epub 2019 Oct 28.
• Ammar AS, Mahmoud KM. Comparative effect of propofol versus sevoflurane on renal ischemia/reperfusion injury after elective open abdominal aortic aneurysm repair. Saudi J Anaesth. 2016 Jul-Sep;10(3):301-7. doi: 10.4103/1658-354X.174907.
• Loggi S, Mininno N, Damiani E, Marini B, Adrario E, Scorcella C, Domizi R, Carsetti A, Pantanetti S, Pagliariccio G, Carbonari L, Donati A. Changes in the sublingual microcirculation following aortic surgery under balanced or total intravenous anaesthesia: a prospective observational study. BMC Anesthesiol. 2019 Jan 5;19(1):1. doi: 10.1186/s12871-018-0673-7.
• Giudice V, Lauwick S, Kaba A, Joris J. [Proven and expected benefits of intravenous lidocaine administered during the perioperative period]. Rev Med Liege. 2012 Feb;67(2):81-4. French.
• Liu FL, Chen TL, Chen RM. Mechanisms of ketamine-induced immunosuppression. Acta Anaesthesiol Taiwan. 2012 Dec;50(4):172-7. doi: 10.1016/j.aat.2012.12.001. Epub 2013 Jan 11.
• Mojtahedzadeh M, Chelkeba L, Ranjvar-Shahrivar M, Najafi A, Moini M, Najmeddin F, Sadeghi K, Barkhordari K, Gheymati A, Ahmadi A. Randomized Trial of the Effect of Magnesium Sulfate Continuous Infusion on IL-6 and CRP Serum Levels Following Abdominal Aortic Aneurysm Surgery. Iran J Pharm Res. 2016 Fall;15(4):951-956.
• Marik PE. Propofol: an immunomodulating agent. Pharmacotherapy. 2005 May;25(5 Pt 2):28S-33S. doi: 10.1592/phco.2005.25.5_part_2.28s.
• Roeckel LA, Utard V, Reiss D, Mouheiche J, Maurin H, Robe A, Audouard E, Wood JN, Goumon Y, Simonin F, Gaveriaux-Ruff C. Morphine-induced hyperalgesia involves mu opioid receptors and the metabolite morphine-3-glucuronide. Sci Rep. 2017 Sep 4;7(1):10406. doi: 10.1038/s41598-017-11120-4.
• Yi P, Pryzbylkowski P. Opioid Induced Hyperalgesia. Pain Med. 2015 Oct;16 Suppl 1:S32-6. doi: 10.1111/pme.12914.
• Mauermann E, Filitz J, Dolder P, Rentsch KM, Bandschapp O, Ruppen W. Does Fentanyl Lead to Opioid-induced Hyperalgesia in Healthy Volunteers?: A Double-blind, Randomized, Crossover Trial. Anesthesiology. 2016 Feb;124(2):453-63. doi: 10.1097/ALN.0000000000000976.

Study record dates

Study Major Dates

• Study Start (Actual): October 8, 2020
• Primary Completion (Estimated): October 8, 2025
• Study Completion (Estimated): October 8, 2027

Study Registration Dates

• First Submitted: April 19, 2021
• First Submitted That Met QC Criteria: May 16, 2021
• First Posted (Actual): May 20, 2021

Study Record Updates

• Last Update Posted (Estimated): January 8, 2024
• Last Update Submitted That Met QC Criteria: January 5, 2024
• Last Verified: January 1, 2024

More Information

Terms related to this study

• Keywords: Cytokines; Opioid-free Anesthesia-Analgesia; Opioid-based Anesthesia-Analgesia; Immunomodulation; Inflammatory Markers; Haemodynamic Stability; Open Abdominal Aortic Aneurysm Repair
• Additional Relevant MeSH Terms: Cardiovascular Diseases; Vascular Diseases; Wounds and Injuries; Aortic Diseases; Rupture; Aneurysm; Aortic Aneurysm; Aortic Aneurysm, Abdominal; Physiological Effects of Drugs; Central Nervous System Depressants; Peripheral Nervous System Agents; Analgesics; Sensory System Agents; Narcotics; Anesthetics; Analgesics, Opioid
• Other Study ID Numbers: OFA-aneurysm

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: Yes